复发性早期子宫内膜癌:复发模式与挽救治疗结果
该研究回顾了2000至2016年间2691例FIGO I-II期子宫内膜癌患者,中位随访6.1年,总复发率7.2%,局部区域复发率3.7%。仅阴道复发者复发后中位总生存为14.0年,优于盆腔复发(1.2年)和远处复发(1.0年);仅阴道复发者中挽救性放疗与总生存改善相关(HR 0.1,p=.04)。
要点
- 早期子宫内膜癌总复发率7.2%,局部区域复发率3.7%。
- 仅阴道复发者中位总生存14.0年,优于盆腔复发1.2年和远处复发1.0年。
- 仅阴道复发者中挽救性放疗与总生存改善相关(HR 0.1,p=.04)。
核心结论
- 早期子宫内膜癌患者失败率低;仅阴道复发者总生存优于盆腔或远处复发;挽救性放疗似乎是仅阴道复发治疗的重要因素;积极的多模式治疗可能对盆腔复发有益。
研究设计与样本
- 单机构回顾性分析,纳入2000至2016年诊断为FIGO I-II期、任何级别、至少接受子宫切除术的子宫内膜癌女性,共2691例。
主要发现
- 中位随访6.1年,总复发率7.2%,局部区域复发率3.7%。
- 仅阴道复发者复发后中位总生存14.0年,盆腔复发者1.2年,远处复发者1.0年。
- 仅阴道复发者中,挽救性放疗是唯一与总生存改善相关的因素(HR 0.1,p=.04)。
- 盆腔复发者中,挽救性手术(HR 0.3,p=.01)、挽救性放疗(HR 0.3,p<.01)和挽救性化疗(HR 0.4,p=.03)与总生存改善相关。
临床怎么用
- 作者认为,挽救性放疗似乎是仅阴道复发治疗的重要因素;积极的多模式治疗可能对盆腔复发有益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze our institutional experience and oncologic outcomes for salvage treatment for the recurrence of early-stage endometrial cancer patients. METHODS: We included women of all ages diagnosed with FIGO stage I-II, any grade endometrial cancer from 2000 to 2016 at our institutions who were treated with at least a hysterectomy. Recurrences in the pelvis and/or vagina were considered locoregional recurrences (LRR). Overall survival (OS) was assessed using Kaplan-Meier survival analysis. Univariate (UV) and multivariate (MV) Cox proportional hazards modeling was also used. RESULTS: A total of 2691 women were analyzed. The majority had endometrioid histology (91%), stage IA disease (61%), and were grade 1 (57%). With a median follow-up of 6.1 years, the overall rate of recurrence was 7.2%, and the rate of LRR was 3.7%. Women with vaginal-only recurrences had a longer median OS after recurrence (14.0 years) compared to both pelvic (1.2 years) and distant (1.0 year) failures. For women with vaginal-only recurrences, salvage radiotherapy (RT) was the only factor associated with improved OS on MVA (HR 0.1, p = .04). For women with pelvic recurrences, salvage surgery (HR 0.3, p = .01), salvage RT (HR 0.3, p < .01), and salvage chemotherapy (HR 0.4, p = .03) were associated with improved OS. CONCLUSIONS: Failure rates for women with early-stage endometrial cancer are low. Women with vaginal-only recurrences have improved OS compared to pelvic or distant recurrences. Salvage RT appears to be an important factor for treatment of women with vaginal-only recurrences. Aggressive multimodality treatment may be beneficial for women with pelvic recurrences.
引用
- Francis SR, Ager BJ, Do OA, et al. Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy. Gynecol Oncol. 2019. PMID: 31029507. doi:10.1016/j.ygyno.2019.04.676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。